期刊
VETERINARY MICROBIOLOGY
卷 253, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.vetmic.2020.108954
关键词
Tigecycline resistance; Tet(X); A. baumannii; Clonal spread; ISCR2; IS26
资金
- National Key Research and Development Program of China [2016YFD0501300]
- Program for Innovative Research Team in the University of Ministry of Education of China [IRT_17R39]
The recent discovery of plasmid-mediated tigecycline-resistant gene tet(X) in sick ducks and chickens in Guangdong, China, challenges the clinical effectiveness of tigecycline. The isolates exhibited high degradation activities on tetracyclines by hydroxylation and showed multidrug resistance to several antibiotics. Additional efforts are needed to evaluate the clinical impact of these tigecycline resistance genes.
The recent emergence of plasmid-mediated tigecycline resistance gene tet(X) has challenged the clinical effectiveness of tigecycline as a last-resort treatment option. During 2017-2018, 336 fecal samples from sick ducks, pigs, chickens and geese in Guangdong, China, were screened for tet(X)-positive Acinetobacter baumannii strains. Their activities on tetracyclines were determined by microbiological degradation and mass spectrometry, followed by susceptibility testing, sequence typing, gene transfer, molecular location and genomic DNA sequencing analyses. A total of 10 tet(X)-positive A. baumannii strains were isolated from ducks and chickens, including eight plasmid-borne tet(X5)-positive and two chromosomal tet(X6)-positive isolates. All of them exhibited good degradation activities on tetracyclines by hydroxylation at C11a and were multidrug-resistant to tigecycline, tetracycline, florfenicol, ciprofloxacin and trimethoprim/sulfamethoxazole. Genetically, they belonged to two sequence types (ST355, n = 8; ST1980, n = 2) that were consistent with their pulsotypes, revealing a clonal spread of ST355 A. baumannii. An ISCR2- or IS26-mediated tet(X) transposition structure, homologous to those of clinical A. baumannii strains, was also identified and ISCR2 could transfer tet(X5) into the recipient Acinetobacter baylyi ADP1 at a frequency of (1.8 +/- 0.3)x10(-6). Therefore, more efforts are needed to evaluate the clinical impact of these tigecycline resistance genes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据